Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Predicting severe outcomes in patients with corrosive ingestion using early clinical and laboratory variables: A
Nguyen Dang Duc1, Hoang Minh Thang2, Hoang Minh Tri2
1Toxicologist, Poison Control Center, Bach Mai Hospital, Hanoi, Vietnam.
Abstract:
Early risk stratification after corrosive ingestion is challenging, particularly in low and middle-income countries where endoscopy and advanced imaging may not be immediately available. We aimed to develop a pragmatic early predictive model based solely on readily obtainable clinical and laboratory variables at admission. The final model demonstrated good calibration and excellent discrimination, supporting its potential role as an early triage tool.
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
